Evogene
EVGN
24 hedge funds and large institutions have $28.8M invested in Evogene in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
26% more funds holding
Funds holding: 19 → 24 (+5)
0.49% more ownership
Funds ownership: 3.09% → 3.58% (+0.49%)
25% less capital invested
Capital invested by funds: $38.3M → $28.8M (-$9.55M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.71M |
| 2 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
+$542K |
| 3 |
MCM
Moon Capital Management
New York
|
+$470K |
| 4 |
JP Morgan Chase
New York
|
+$295K |
| 5 |
Jane Street
New York
|
+$267K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$118K |
| 2 |
SWM
Stockman Wealth Management
Billings,
Montana
|
-$18K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4K |
EVGN Hedge Fund Activity: Q4 2017 in Review
24 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q4 2017, worth a combined $28.8M — down 25% from $38.3M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new EVGN positions and 1 closed out — a net gain of 5 holders — while 8 added to existing stakes and 2 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.71M. The largest seller was Canada Pension Plan Investment Board, cutting an estimated $118K.
- 24 institutional investors held Evogene (EVGN) as of Q4 2017, up from 19 in Q3 2017.
- Funds reported $28.8M of Evogene stock for Q4 2017, down 25% quarter-over-quarter.
- 6 funds opened new Evogene positions in Q4 2017 and 1 closed out, a net change of +5 holders.
- The largest Evogene buyer in Q4 2017 was Morgan Stanley, an estimated $1.71M added.
- The largest Evogene seller in Q4 2017 was Canada Pension Plan Investment Board, an estimated $118K sold.
Based on aggregated 13F filings for Q4 2017.